云顶新耀-B(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01952 云顶新耀-B

未开盘 11-18 16:08:08

34.500

-0.650

-1.85%

最高35.400	最低33.500	成交量303.90万
今开35.150	昨收35.150	日振幅5.41%
总市值112.21亿	流通市值112.21亿	总股本3.25亿
成交额1.05亿	换手率0.93%	流通股本3.25亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01952","market":"HK","secType":"STK","nameCN":"云顶新耀-B","latestPrice":34.5,"timestamp":1731917288014,"preClose":35.15,"halted":0,"volume":3039000,"delay":0,"floatShares":325252818,"shares":325252818,"eps":-2.9042726,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.65,"latestTime":"11-18 16:08:08","open":35.15,"high":35.4,"low":33.5,"amount":104881300,"amplitude":0.054054,"askPrice":34.7,"askSize":500,"bidPrice":34.5,"bidSize":10500,"shortable":3,"etf":0,"ttmEps":-3.5214345023000586,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"listingDate":1602172800000,"adjPreClose":35.15,"openAndCloseTimeList":[[1731893400000,1731902400000],[1731906000000,1731916800000]],"volumeRatio":0.6878751624290096,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01952","defaultTab":"news","newsList":[{"id":"2484261001","title":"云顶新耀-B11月18日主力资金流出325万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484261001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484261001?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:16","pubTimestamp":1731917782,"startTime":"0","endTime":"0","summary":"11月18日, 云顶新耀-B股价跌1.85%，报收34.50元，成交金额1.05亿元，换手率0.93%，振幅5.41%，量比0.69。云顶新耀-B今日主力资金净流出325万元，连续5日净流出，上一交易日主力净流出589万元，今日环比减少44.82%。该股近5个交易日下跌4.70%，主力资金累计净流出1870万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入7040万元，其中净流入天数为8日。该股主力净额占比0.03%，港股市场排名2538/2642。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118161706abcbdabe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118161706abcbdabe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01952","BK1583"],"gpt_icon":0},{"id":"2484324661","title":"云顶新耀更换核数师，安永接任罗兵咸","url":"https://stock-news.laohu8.com/highlight/detail?id=2484324661","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484324661?lang=zh_cn&edition=full","pubTime":"2024-11-18 09:10","pubTimestamp":1731892219,"startTime":"0","endTime":"0","summary":"云顶新耀-B（01952）发布公告，宣布更换核数师。经过董事会的评估，考虑到罗兵咸永道会计师事务所自2018年起一直担任公司核数师，董事会决定更换核数师以提升年度审计的成本效益并维持良好的企业管治。由于未能就2024财年的核数师薪酬与罗兵咸达成共识，罗兵咸已同意自2024年11月15日起辞任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411183242082321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","01952","BK1574","BK1161"],"gpt_icon":0},{"id":"2484667316","title":"云顶新耀(01952.HK)核数师变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2484667316","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484667316?lang=zh_cn&edition=full","pubTime":"2024-11-18 09:03","pubTimestamp":1731891780,"startTime":"0","endTime":"0","summary":"云顶新耀-B(01952.HK) 公布，而罗兵咸已同意辞任为公司核数师，自上周五(15日)起生效。另外，云顶新耀已议决委任安永会计师事务所为公司新任核数师，自上周五起生效，以填补罗兵咸辞任后的临时空缺，并将任职直至公司下届股东周年大会结束为止。(js/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-15 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210311103606358_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210311103606358_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397259/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1583","01952","BK1574"],"gpt_icon":0},{"id":"2483322183","title":"云顶新耀-B委任安永为核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2483322183","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483322183?lang=zh_cn&edition=full","pubTime":"2024-11-15 20:07","pubTimestamp":1731672473,"startTime":"0","endTime":"0","summary":"格隆汇11月15日丨云顶新耀-B(01952.HK)公告，鉴于公司无法与罗兵咸就截至2024年12月31日止财政年度的核数师薪酬达成共识，为了加强公司年度审计的成本效益并让公司能够维持良好企业管治，董事会已通知罗兵咸关于更换核数师的建议，而罗兵咸已同意辞任为公司核数师，自2024年11月15日起生效。董事会在审核委员会建议下，已议决委任安永会计师事务所为公司新任核数师，自2024年11月15日起生效，以填补罗兵咸辞任后的临时空缺并将任职直至公司下届股东周年大会结束为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115200753a23b0b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115200753a23b0b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","01952","BK1574"],"gpt_icon":0},{"id":"2483534807","title":"云顶新耀-B11月15日遭主力抛售589万元 环比增加208.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483534807","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483534807?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:15","pubTimestamp":1731658550,"startTime":"0","endTime":"0","summary":"11月15日, 云顶新耀-B股价涨1.01%，报收35.15元，成交金额1.15亿元，换手率1.00%，振幅5.32%，量比0.62。云顶新耀-B今日主力资金净流出589万元，连续4日净流出，上一交易日主力净流出191万元，今日环比增加208.38%。该股近5个交易日下跌2.89%，主力资金累计净流出1385万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入7927万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161610abc3df81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161610abc3df81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1583","01952"],"gpt_icon":0},{"id":"2483957893","title":"云顶新耀-B(01952)上涨5.28%，报36.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483957893","media":"金融界","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483957893?lang=zh_cn&edition=full","pubTime":"2024-11-14 10:01","pubTimestamp":1731549699,"startTime":"0","endTime":"0","summary":"11月14日，云顶新耀-B(01952)盘中上涨5.28%，截至10:01，报36.9元/股，成交3996.14万元。云顶新耀有限公司是一家专门从事创新药和疫苗的研发、临床开发、制造和商业化的生物制药公司，主要服务大中华区和其他亚洲市场。公司在药物和疫苗的自主研发上表现优异，同时在肾科疾病、mRNA平台、感染性和传染性疾病、自身免疫性疾病等领域已建立全球同类首创或者同类最佳的药物和疫苗组合。截至2024年中报，云顶新耀-B营业总收入3.02亿元、净利润-6.32亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14100145277262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01952","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2483893490","title":"云顶新耀-B盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483893490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483893490?lang=zh_cn&edition=full","pubTime":"2024-11-14 10:01","pubTimestamp":1731549690,"startTime":"0","endTime":"0","summary":"2024年11月14日早盘10时01分，云顶新耀-B股票出现波动，股价大幅拉升5.28%。截至发稿，该股报36.900港元/股，成交量111.4万股，换手率0.34%，振幅6.42%。云顶新耀-B股票所在的生物技术行业中，整体跌幅为0.85%。云顶新耀-B公司简介：云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114100130a235a29d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114100130a235a29d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01952","BK1574","BK1583"],"gpt_icon":0},{"id":"2483024618","title":"云顶新耀-B11月13日遭主力抛售620万元 环比增加324.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483024618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483024618?lang=zh_cn&edition=full","pubTime":"2024-11-13 16:15","pubTimestamp":1731485733,"startTime":"0","endTime":"0","summary":"11月13日, 云顶新耀-B股价跌3.31%，报收35.05元，成交金额1.39亿元，换手率1.22%，振幅7.03%，量比0.83。云顶新耀-B今日主力资金净流出620万元，上一交易日主力净流出146万元，今日环比增加324.66%。该股近5个交易日上涨8.35%，主力资金累计净流入711万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.19亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161551a2332314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161551a2332314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01952","BK1583","BK1574"],"gpt_icon":0},{"id":"2483601515","title":"云顶新耀-B盘中异动 早盘大幅下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483601515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483601515?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:33","pubTimestamp":1731465218,"startTime":"0","endTime":"0","summary":"2024年11月13日早盘10时33分，云顶新耀-B股票出现波动，股价急速下跌5.10%。截至发稿，该股报34.400港元/股，成交量143万股，换手率0.44%，振幅5.66%。云顶新耀-B股票所在的生物技术行业中，整体跌幅为2.23%。云顶新耀-B公司简介：云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111310333898e4240c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111310333898e4240c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01952","BK1161","BK1583"],"gpt_icon":0},{"id":"2482924713","title":"港股异动 | 云顶新耀-B(01952)涨超3% 临床潜在需求巨大 耐赋康有望在国内市场迎来爆发期","url":"https://stock-news.laohu8.com/highlight/detail?id=2482924713","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482924713?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:21","pubTimestamp":1731378069,"startTime":"0","endTime":"0","summary":"值得关注的是，在今年的国家医保谈判中，云顶新耀携耐赋康作为新兴生物医药企业的代表位列谈判企业，一系列的临床及商业化的进展预示着耐赋康这一创新产品即将迎来爆发期。而作为目前国内首个且唯一获批的IgA肾病对因治疗药物，减少50%的肾功能恶化，预计将疾病进展至透析或肾移植的时间延缓12.8年，市场对耐赋康有着巨大需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","01952","BK1574"],"gpt_icon":0},{"id":"2482246484","title":"云顶新耀-B(01952)耐赋康®近期连续发布重磅研究数据并取得关键进展  国内市场有望步入爆发期","url":"https://stock-news.laohu8.com/highlight/detail?id=2482246484","media":"智通财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482246484?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:40","pubTimestamp":1731292829,"startTime":"0","endTime":"0","summary":"近日，港股创新药企云顶新耀-B重磅产品——全球首个IgA肾病对因治疗药物耐赋康NefIgArd III期临床试验的全球开放标签扩展研究，在美国肾脏病协会肾脏周上公布积极数据。此外，耐赋康近日连续在ASN Kidney Week 2024和顶级期刊《肾脏360》发布多项重磅研究数据，并在中国台湾地区获批上市。业内耐赋康的商业化前景给予高期待，同时认为基于庞大的患者人群和显著的疗效，以及不断提升的药品可及性，耐赋康国内市场有望进入爆发期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","01952","BK1574"],"gpt_icon":0},{"id":"2481914355","title":"港股异动 | 云顶新耀-B(01952)涨超11% 医保谈判支持创新药 伊曲莫德预计年内可提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2481914355","media":"智通财经","labels":["Policy And Regulatory","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481914355?lang=zh_cn&edition=full","pubTime":"2024-11-08 15:25","pubTimestamp":1731050715,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，云顶新耀-B涨超11%，截至发稿，涨11.08%，报36.1港元，成交额2.48亿港元。新版医保药品目录预计于11月底对外发布，明年1月1日起正式实施。据悉，云顶新耀耐赋康参与今年国家医保谈判。云顶新耀首席执行官罗永庆表示，很高兴看到伊曲莫德的完整诱导期研究数据取得具有临床意义和统计学显著性的积极结果，并预计将在今年年底前，向中国国家药品监督管理局递交新药上市许可申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","BK1583","01952","BK1574","159992","BK1161"],"gpt_icon":0},{"id":"2481811554","title":"云顶新耀-B(01952)上涨10.0%，报35.75元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481811554","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481811554?lang=zh_cn&edition=full","pubTime":"2024-11-08 13:26","pubTimestamp":1731043592,"startTime":"0","endTime":"0","summary":"11月8日，云顶新耀-B(01952)盘中上涨10.0%，截至13:26，报35.75元/股，成交1.58亿元。云顶新耀有限公司是一家专门从事创新药和疫苗的研发、临床开发、制造和商业化的生物制药公司，主要服务大中华区和其他亚洲市场。公司在药物和疫苗的自主研发上表现优异，同时在肾科疾病、mRNA平台、感染性和传染性疾病、自身免疫性疾病等领域已建立全球同类首创或者同类最佳的药物和疫苗组合。截至2024年中报，云顶新耀-B营业总收入3.02亿元、净利润-6.32亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/08132645072369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","01952","BK1161","BK1574"],"gpt_icon":0},{"id":"2481416046","title":"港股异动 | 部分医药股走高 医保谈判支持创新药 机构指板块仍有进一步修复空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2481416046","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481416046?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:48","pubTimestamp":1731034083,"startTime":"0","endTime":"0","summary":"消息面上，据国家医保局此前介绍，2024年国家医保药品目录调整现场谈判已顺利结束，“扩容”后的新版医保药品目录预计于11月底对外发布，2025年1月1日起正式实施。西南证券表示，创新药国谈和三季报落地。创新药国谈方向投资机会值得期待。交银国际表示，近期医药板块在大幅震荡后小幅回升，考虑到板块估值仍处于历史底部、叠加后续宏观利好政策出台+流动性改善，该行认为仍有进一步修复空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1515","02171","01952","BK1583","BK1161","06978","02157","BK1585","159992","09966","BK1587","09939","BK1574"],"gpt_icon":0},{"id":"1112239296","title":"异动解读 | 云顶新耀-B盘中大涨5% 生物制药行业表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1112239296","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112239296?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:15","pubTimestamp":1731032139,"startTime":"0","endTime":"0","summary":"2024年11月8日上午,云顶新耀-B股价在港股市场盘中出现大涨,最高上涨5.08%,报收34.15港元/股,引发市场广泛关注。云顶新耀是一家总部位于香港的生物制药公司,主要从事创新药物和疫苗的研发、临床开发和商业化运营。值得关注的是,云顶新耀所处的生物技术行业当日整体表现活跃,板块内多只个股亦出现不同程度上涨。另外,有60%分析机构给予云顶新耀\"买入\"评级,看好其发展前景,也为股价上涨增添利好支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 云顶新耀-B盘中大涨5% 生物制药行业表现亮眼","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01952"],"gpt_icon":0},{"id":"2481161211","title":"云顶新耀-B盘中异动 快速拉升5.08%报34.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481161211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481161211?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:08","pubTimestamp":1731031696,"startTime":"0","endTime":"0","summary":"2024年11月08日早盘10时08分，云顶新耀-B股票出现波动，股价急速拉升5.08%。截至发稿，该股报34.150港元/股，成交量120.028万股，换手率0.37%，振幅4.15%。资金方面，该股资金流入2897.57万港元，流出690.327万港元。云顶新耀-B股票所在的生物技术行业中，整体涨幅为0.81%。云顶新耀-B公司简介：云顶新耀有限公司是一家主要从事创新药及疫苗研发、临床开发、制造及商业化的生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108100816971a53f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108100816971a53f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","01952","BK1574"],"gpt_icon":0},{"id":"2481286929","title":"云顶新耀-B11月07日主力资金流出330万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481286929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481286929?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:17","pubTimestamp":1730967444,"startTime":"0","endTime":"0","summary":"11月07日, 云顶新耀-B股价涨0.46%，报收32.50元，成交金额8185万元，换手率0.78%，振幅4.79%，量比0.59。云顶新耀-B今日主力资金净流出330万元，连续3日净流出，上一交易日主力净流出366万元，今日环比减少9.84%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为40.00%，平均跌幅为3.85%。该股近5个交易日上涨3.17%，主力资金累计净流入111万元；近20日主力资金累计净流入1.05亿元，其中净流入天数为11日。该股主力净额占比0.03%，港股市场排名2535/2643。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107161831a21fc2b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107161831a21fc2b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","01952","BK1161"],"gpt_icon":0},{"id":"2481994090","title":"医药股普遍下行 金斯瑞生物科技(01548)跌超3% 第十批国采药品目录官宣 机构料续淘汰力度将加大","url":"https://stock-news.laohu8.com/highlight/detail?id=2481994090","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481994090?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:54","pubTimestamp":1730944476,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股普遍下行，荣昌生物 跌4.09%，药明巨诺、金斯瑞生物科技跌超3%，基石药业、百济神州跌逾2%，和黄医药跌1.55%，先声药业跌1.47%，康方生物跌1.19%，云顶新耀跌1.08%。2024年国家医保药品目录调整现场谈判已结束，新目录预计11月底公布，明年1月1日正式实施，涉及127家企业162种药品。此次国采品种数量和入围门槛均为历史之最，预计后续淘汰力度将加大，注射剂比例创新高，将改变相关药企的竞争格局。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947254","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","IE00B5MMRT66.SGD","BK1515","LU0348783233.USD","BK1574","LU1794554557.SGD","BK1588","00013","IE00BPRC5H50.USD","HK0000306685.HKD","02096","HK0000320223.HKD","HK0000306701.USD","HK0000320264.USD","LU0417516571.SGD","06160","BK1161","09926","02616","BK1583","01952","BK1576","09939","BK1500","BK1587","IE00B543WZ88.USD","BK1191","159938","LU0348784397.USD","BK1141","LU1969619763.USD","09995","LU0307460666.USD","LU2328871848.SGD","LU0588546209.SGD","02126","LU2488822045.USD","LU1720050803.USD"],"gpt_icon":0},{"id":"2481940999","title":"交银国际：第十批国采启动报量 看好板块情绪改善+医保谈判落地后的估值修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2481940999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481940999?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:19","pubTimestamp":1730942392,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研究报告称，11月1日，药品联合采购办公室发布《关于开展第十批国家组织药品集中采购相关药品信息填报工作的通知》，宣布第十批国采正式启动。报告中称，2024年国家医保药品目录调整现场谈判结束。新版医保药品目录预计于11月底对外发布，明年1月1日起正式实施。此次谈判时间为10月27日到30日中午，共涉及127家企业、162种药品，其中医保目录外药品117种，医保目录内谈判续约药品45种。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09926","BK1147","LU1794554557.SGD","IE00B5MMRT66.SGD","LU1720050803.USD","LU0417516571.SGD","LU0348783233.USD","00013","03329","01952","BK1574","02096","BK1588","IE00BPRC5H50.USD","LU0348784397.USD","BK1583","IE00B543WZ88.USD","LU2488822045.USD","BK1587","BK1161","BK1191"],"gpt_icon":0},{"id":"2480232982","title":"港股异动 | 云顶新耀-B(01952)午后涨超8% 国家医保谈判已结束 机构看好创新品种纳入医保放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2480232982","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480232982?lang=zh_cn&edition=full","pubTime":"2024-11-04 14:33","pubTimestamp":1730701987,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，云顶新耀-B午后涨超8%，截至发稿，涨6.94%，报33.15港元，成交额1.95亿港元。据悉，云顶新耀参与今年国家医保谈判。湘财证券指出，创新药国谈制度已常态化，看好创新品种纳入医保放量投资机会。值得注意的是，10月25日，云顶新耀宣布，创新药伊曲莫德获得“粤港澳大湾区内地临床急需进口港澳药品批件”批准，将在指定医疗机构先行使用，这是15个月内云顶新耀获批的第3款产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK1583","01952"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.everestmedicines.com","stockEarnings":[{"period":"1week","weight":-0.047},{"period":"1month","weight":0.2084},{"period":"3month","weight":0.8177},{"period":"6month","weight":0.4526},{"period":"1year","weight":0.2523},{"period":"ytd","weight":0.6507}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"云顶新耀有限公司是一家主要从事疗法的特许、临床开发及商业化业务，以解决尚未满足的医疗需求。该公司一直专注于创新候选药物的研发。该公司已开发极具前景的临床阶段候选药物产品组合，覆盖肿瘤、免疫学、心肾疾病及感染性疾病。该公司主要在大中华及亚太区其他新兴市场提供产品与服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.043978},{"month":2,"riseRate":0.25,"avgChangeRate":0.025861},{"month":3,"riseRate":0.25,"avgChangeRate":-0.030941},{"month":4,"riseRate":0.25,"avgChangeRate":-0.098869},{"month":5,"riseRate":0.5,"avgChangeRate":-0.010924},{"month":6,"riseRate":0.75,"avgChangeRate":0.281644},{"month":7,"riseRate":0,"avgChangeRate":-0.15054},{"month":8,"riseRate":0.25,"avgChangeRate":-0.139716},{"month":9,"riseRate":0.75,"avgChangeRate":0.086225},{"month":10,"riseRate":0.5,"avgChangeRate":0.00246},{"month":11,"riseRate":0.6,"avgChangeRate":0.112154},{"month":12,"riseRate":0.75,"avgChangeRate":0.148847}],"exchange":"SEHK","name":"云顶新耀-B","nameEN":"EVEREST MED - B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云顶新耀-B(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云顶新耀-B(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云顶新耀-B,01952,云顶新耀-B股票,云顶新耀-B股票老虎,云顶新耀-B股票老虎国际,云顶新耀-B行情,云顶新耀-B股票行情,云顶新耀-B股价,云顶新耀-B股市,云顶新耀-B股票价格,云顶新耀-B股票交易,云顶新耀-B股票购买,云顶新耀-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云顶新耀-B(01952)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云顶新耀-B(01952)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}